Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 6
2006 5
2007 4
2008 5
2009 6
2010 4
2011 6
2012 4
2013 4
2014 7
2015 9
2016 5
2017 16
2018 12
2019 6
2020 7
2021 11
2022 12
2023 18
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Results by year

Filters applied: . Clear all
Page 1
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hirschfield GM, Shiffman ML, Gulamhusein A, Kowdley KV, Vierling JM, Levy C, Kremer AE, Zigmond E, Andreone P, Gordon SC, Bowlus CL, Lawitz EJ, Aspinall RJ, Pratt DS, Raikhelson K, Gonzalez-Huezo MS, Heneghan MA, Jeong SH, Ladrón de Guevara AL, Mayo MJ, Dalekos GN, Drenth JPH, Janczewska E, Leggett BA, Nevens F, Vargas V, Zuckerman E, Corpechot C, Fassio E, Hinrichsen H, Invernizzi P, Trivedi PJ, Forman L, Jones DEJ, Ryder SD, Swain MG, Steinberg A, Boudes PF, Choi YJ, McWherter CA; ENHANCE Study Group*. Hirschfield GM, et al. Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6. Hepatology. 2023. PMID: 37386786 Free PMC article. Clinical Trial.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.
Aggeletopoulou I, Kalafateli M, Tsounis EP, Triantos C. Aggeletopoulou I, et al. Among authors: triantos c. Int J Mol Sci. 2023 Aug 16;24(16):12864. doi: 10.3390/ijms241612864. Int J Mol Sci. 2023. PMID: 37629043 Free PMC article. Review.
Intestinal barrier dysfunction as a key driver of severe COVID-19.
Tsounis EP, Triantos C, Konstantakis C, Marangos M, Assimakopoulos SF. Tsounis EP, et al. Among authors: triantos c. World J Virol. 2023 Mar 25;12(2):68-90. doi: 10.5501/wjv.v12.i2.68. World J Virol. 2023. PMID: 37033148 Free PMC article. Review.
COVID-19 Vaccination in Patients with Chronic Liver Disease.
Schinas G, Polyzou E, Mitropetrou F, Pazionis A, Gogos C, Triantos C, Akinosoglou K. Schinas G, et al. Among authors: triantos c. Viruses. 2022 Dec 13;14(12):2778. doi: 10.3390/v14122778. Viruses. 2022. PMID: 36560782 Free PMC article. Review.
The Influence of Nutritional Factors on Immunological Outcomes.
Tourkochristou E, Triantos C, Mouzaki A. Tourkochristou E, et al. Among authors: triantos c. Front Immunol. 2021 May 31;12:665968. doi: 10.3389/fimmu.2021.665968. eCollection 2021. Front Immunol. 2021. PMID: 34135894 Free PMC article. Review.
145 results